Insights On Drug Development

1. Mobilizing Science, Partnership, And Capability To Develop A Gene Therapy In 14 Months 9/17/2025

   Hear how one family, driven by urgency, partnered with AAV experts to develop a treatment for their daughter’s ultra-rare neurodegenerative disorder, NEDAMSS, in just 14 months.

2. Nitrosamine Testing: How To Ensure Regulatory Compliance, Product Safety 9/16/2025

   Explore what nitrosamines are, why testing matters, and how we're able to deliver high-confidence solutions through advanced science and industry-leading expertise.

3. Thermofluor Screening For Injectable Protein Formulations 9/15/2025

   The results herein highlight thermofluor screening as a versatile and efficient platform for rational formulation of injectable biologics through the acceleration of stable drug product development.

4. Preclinical Technique To Assess Targeted Therapies For Primary, Metastatic NSCLC 9/13/2025

   To enable comprehensive evaluation of therapies targeting both primary and metastatic tumors, we've developed dual-disease xenograft models using bioluminescence imaging (BLI).

5. Unlock The 3 Keys To Drug Discovery Success — Foresight, Hindsight, And Insight 9/13/2025

   If you don’t know where you are going, how will you get there? Articulating the destination of your therapeutic is essential for determining whether it is commercially viable and meets required milestones.

6. Developing A Control Strategy And Minimizing Risk In Phase 1 Injectable Drug Development 9/11/2025

   See how investing early in the right controls not only minimizes risks but also accelerates timelines, streamlines regulatory interactions, and builds trust across the ecosystem.

7. Early-Stage Drug Development: Navigating The Trends That Shape Tomorrow's Therapies 9/11/2025

   From AI to adaptive trial designs, the industry is undergoing a transformation that is equal parts scientific breakthrough and strategic recalibration. Learn what innovations are poised to redefine pipelines.

8. Nanoforming Biologics, GLP-1s: From I.V. To Sub Q And Inhaled Delivery 9/9/2025

   Nanoforming enables new delivery routes for biologics and peptides to simplify dosing, enhance patient comfort, and reduce healthcare costs.

9. Development Of A Non-Standard Protein Therapeutic 9/9/2025

   Discover how a tailored development approach transformed a complex therapeutic protein into a candidate ready for early-stage clinical trials.

10. Phenotypic Characterization Of Bleomycin-Induced Pulmonary Fibrosis Mod 9/8/2025

    To gain deeper biological insight, lung injury in this model has been further characterized through cellular phenotyping, gene expression analysis, and cytokine profiling.